← Back to Search

Mindful Motivation for Binge Eating

N/A

Waitlist Available

Led By Rachel Radin, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 years or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to post-intervention, an anticipated average of 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test a new eating intervention for overweight individuals with binge eating. The intervention combines mindful eating with motivational interviewing to target binge eating. Researchers want to find out if participants find the intervention acceptable

Who is the study for?

This trial is for individuals who are overweight and struggle with binge eating. Participants will be asked to complete online questionnaires, provide body composition data, and meditate daily. They must not have conditions that exclude them from the study.

What is being tested?

The trial tests a new intervention combining mindful eating techniques with motivational interviewing against an active control of digital meditation alone. The goal is to see if this approach can reduce binge eating episodes.

What are the potential side effects?

Since the interventions involve behavioral strategies like meditation and counseling, side effects may include increased self-awareness or emotional discomfort but typically do not involve physical side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to post-intervention, an anticipated average of 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to post-intervention, an anticipated average of 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-intervention, an anticipated average of 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Client Satisfaction score, as determined by the total score on the Client Satisfaction Questionnaire (CSQ-8)

Change in Credibility/Expectancy and Satisfaction Questionnaire (CEQ) score, as determined by total score on the CEQ

Percentage of participants attending a booster call # 1

+4 more

Secondary study objectives

Change in Questionnaire on Eating and Weight Patterns (QEWP) frequency of binge eating episodes per month

Change in Reward Based Eating Drive Scale (RED-13) score, as determined by total score on the RED-13.

Change in Weight Efficacy Lifestyle Scale (WEL-SF) score, as determined by total score on the WEL-SF

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindful Motivation GroupExperimental Treatment2 Interventions

Participants will be assigned to a eating intervention that combines general mindfulness (via headspace) with motivational interviewing for mindful eating They will be asked to attend an online counseling session along with three 10-minute booster phone calls. They will be asked to engage with a digital-based mindful eating program once per week over the course of 8 weeks. In addition, participants will have access to optional educational materials on mindful eating and an optional online private support forum after the intervention period is finished.

Group II: Active Control ConditionActive Control1 Intervention

Participants in the meditation intervention group will be assigned to a digitally-based meditation intervention (via Headspace) and asked to use this for at least 10 minutes a day over the course of 8 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Meditation

2021

Completed Phase 3

~2940

0 / 1Eligibility criteria met